Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Besremi vs BAT in Polycythemia Vera (CONTI-PV)
NCT02218047Phase 3Completed
- Sponsor
- AOP Health
- Start
- Nov 2014
- Primary completion
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 12
01
Overview
A Phase 3 trial of ropeginterferon alfa-2b in polycythemia vera (PV), sponsored by AOP Health. Started Nov 2014; status: completed.
02
Drugs
ropeginterferon alfa-2b
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on NCT02218047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02218047.